−1.10TWD
−57.03 MTWD
384.41 MTWD
40.08 M
About DABOMB PROTEIN BIOTECH CO
Sector
CEO
Yu Fen Liu
Headquarters
Tainan
Website
Founded
2001
ISIN
TW0006578008
FIGI
BBG00DB2LSF3
Dabomb Protein Biotech Corp. manufactures and supply hydrolyzed soya peptide. Its product include hydrolyzed soya peptide, functional peptides and natural L-lactate. The company offers health, environment, pet, agriculture and animal peptides. DaBomb Protein was founded on December 28, 2001 and is headquartered in Tainan, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6578 is 29.05 TWD — it has decreased by 1.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange DABOMB PROTEIN BIOTECH CO stocks are traded under the ticker 6578.
DABOMB PROTEIN BIOTECH CO is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
6578 stock is 4.55% volatile and has beta coefficient of 0.12. Check out the list of the most volatile stocks — is DABOMB PROTEIN BIOTECH CO there?
Yes, you can track DABOMB PROTEIN BIOTECH CO financials in yearly and quarterly reports right on TradingView.
6578 stock has risen by 3.38% compared to the previous week, the month change is a 21.80% rise, over the last year DABOMB PROTEIN BIOTECH CO has showed a 51.30% increase.
6578 net income for the last quarter is −3.34 M TWD, while the quarter before that showed −29.56 M TWD of net income which accounts for 88.69% change. Track more DABOMB PROTEIN BIOTECH CO financial stats to get the full picture.
Today DABOMB PROTEIN BIOTECH CO has the market capitalization of 1.76 B, it has increased by 12.32% over the last week.
Like other stocks, 6578 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DABOMB PROTEIN BIOTECH CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DABOMB PROTEIN BIOTECH CO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DABOMB PROTEIN BIOTECH CO stock shows the buy signal. See more of DABOMB PROTEIN BIOTECH CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DABOMB PROTEIN BIOTECH CO EBITDA is −8.21 M TWD, and current EBITDA margin is −2.14%. See more stats in DABOMB PROTEIN BIOTECH CO financial statements.